Decision-Making Tasks for Short-Term Memory
Trial Summary
What is the purpose of this trial?
Learning to make good decisions in the present, and accurately recalling events and information from the past, are critical aspects of human cognition that are often impaired in many psychiatric disorders. This project aims to identify the how the choices individuals make influence what, and how, people remember by combining disparate techniques in computational modeling and direct brain recordings in human subjects. The researcher developed a dual-task paradigm, probing how decisions in one task affect immediate recognition memory. To examine the neural mechanisms underlying model-free RL's influence on memory, the researcher will record local field potential (LFP) and single neuron activity in various brain regions as epilepsy patients perform the proposed task. The results of this project will identify specific neurocomputational mechanisms unifying decision-making and memory processes.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, since the trial involves epilepsy patients who have not responded to standard treatments, it seems likely that you may continue your current epilepsy medications.
What data supports the effectiveness of the treatment Value-manipulation for short-term memory decision-making tasks?
The research on decision-making nudges suggests that using communication techniques to guide patients' choices can help them make complex decisions more effectively. This implies that value-manipulation, which may involve similar techniques, could potentially improve decision-making in short-term memory tasks by helping individuals focus on important information.12345
How does this treatment for short-term memory differ from other treatments?
This treatment is unique because it focuses on decision-making tasks that involve the brain's ability to update and hold value information over time, using a combination of stable and dynamic neural representations. Unlike traditional treatments that may not address the cognitive processes involved in decision-making, this approach leverages the brain's natural mechanisms for flexible cognitive abilities.678910
Research Team
Salman E Qasim, PhD
Principal Investigator
Icahn School of Medicine at Mt. Sinai
Eligibility Criteria
This trial is for individuals with medication-resistant epilepsy who are already set to receive brain monitoring via intracranial EEG or neurostimulation. Participants must be able to follow the study's procedures, provide consent, and speak English or Spanish. Excluded are those with cognitive impairments, unwillingness to undergo electrode implantation, medical risks for surgery/MRI scans, pregnancy, history of psychosis, recent suicide risk, or other significant brain disorders.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Task Participation
Participants perform decision-making and memory tasks while neural activity is recorded
Follow-up
Participants are monitored for safety and effectiveness after task participation
Treatment Details
Interventions
- Value-manipulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator